Want to see MATV full AI Analyst Report?
Top Page
Mativ Holdings
(NYSE:MATV)
Select Model
Select Model
Rating:61Neutral
Price Target:
$13.50
▲(15.58% Upside)
Action:Reiterated
Date:09/07/26
The score is driven primarily by mixed financials: a clear TTM profitability and cash-flow rebound is tempered by high leverage and thin operating margins. Technicals are supportive with a strong uptrend above major moving averages, though momentum looks stretched. Valuation is a positive contributor due to the low P/E and solid dividend yield.
Positive Factors
Revenue and Profitability Rebound
The strong TTM rebound indicates improved demand, mix, pricing, or operating execution across the business. Returning to profitability after prior losses can restore internal funding capacity, support reinvestment, and provide a stronger base for sustaining growth over the next several quarters.
Negative Factors
Elevated Leverage
Heavy leverage reduces balance-sheet flexibility and leaves more cash flow committed to debt-related obligations. Declining equity further limits resilience, making it harder to absorb weaker demand, fund strategic investment, or manage financing pressure if the operating recovery loses momentum.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and Profitability Rebound
The strong TTM rebound indicates improved demand, mix, pricing, or operating execution across the business. Returning to profitability after prior losses can restore internal funding capacity, support reinvestment, and provide a stronger base for sustaining growth over the next several quarters.
Read all positive factors
Mativ Holdings (MATV) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$698.71M
Dividend Yield3.18%
Average Volume (3M)614.05K
Price to Earnings (P/E)7.7
Beta (1Y)2.12
Revenue Growth1.06%
EPS GrowthN/A
CountryUS
Employees5,000
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)1.63
Shares Outstanding55,190,098
10 Day Avg. Volume581,260
30 Day Avg. Volume614,054
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.33
Price to Sales (P/S)0.33
P/FCF Ratio7.07
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.85
Revenue Forecast (FY)$2.01B
Mativ Holdings Business Overview & Revenue Model
Company Description
Mativ Holdings, Inc. functions as a specialized enterprise dedicated to high-performance materials. The company's operations are divided into two main segments: Advanced Materials & Structures (AMS) and Engineered Papers (EP). The AMS division foc...
How the Company Makes Money
Mativ primarily makes money by manufacturing and selling specialty materials to customers (typically OEMs, converters, and industrial buyers) and recognizing revenue when products are delivered under customer purchase orders and supply agreements....
Mativ Holdings Earnings Call Summary
Earnings Call Date:May 06, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Nov 11, 2026
Earnings Call Sentiment Positive
The call highlighted strong operational progress: meaningful margin expansion (adjusted EBITDA up 28%, margin +220 bps), significant segment-level EBITDA gains (FAM +41%, SAS +16%), improved cash generation and successful refinancing that derisks near-term maturities. Management also executed cost-savings (~$20M realized in 2025) and outlined a formal strategic blueprint and growing commercial pipeline (notably an aerospace films win). Offsetting these positives are near-term demand weaknesses (health care destocking and a temporary plant outage), softness in release liners/labels, a substantial upward revision to expected input cost inflation ($40M–$50M) and leverage that remains above target (net debt ~$954M, net leverage 4.1x). Overall, the company presented multiple concrete actions to protect margins (pricing actions, cost savings, asset optimization) and a clear plan to continue delevering, making the tone constructive despite macro and sector-specific headwinds.Positive Updates
Consolidated Profitability and Margin Expansion
Q1 adjusted EBITDA of $47.5M, up 28% year-over-year; adjusted EBITDA margin of 9.9%, an improvement of 220 basis points versus prior year — described as the strongest consolidated Q1 margin since the mid-2022 merger.
Negative Updates
Revenue Flat to Slight Decline
Consolidated net sales of $480M were nearly flat year-over-year on an organic basis and down ~1% as reported; SAS net sales declined ~2% year-over-year, driven primarily by lower health care volumes.
Read all updates
Q1-2026 Updates
Positive
Negative
Consolidated Profitability and Margin Expansion
Q1 adjusted EBITDA of $47.5M, up 28% year-over-year; adjusted EBITDA margin of 9.9%, an improvement of 220 basis points versus prior year — described as the strongest consolidated Q1 margin since the mid-2022 merger.
Read all positive updates
Company Guidance
Guidance highlights: Mativ expects Q2 adjusted EBITDA to be down a mid-single-digit percentage versus a strong prior year (driven largely by near-term health care volume weakness) while reiterating that pricing actions taken in January and March are intended to fully offset revised 2026 input cost inflation now estimated at $40–$50 million (up from a prior $20–$25 million view); the company is on track for $15–$20 million of cost savings in 2026 after realizing nearly $20 million in 2025, and continues to prioritize debt reduction toward a 2.5–3.5x net leverage goal (Q1 net leverage was 4.1x with net debt ≈ $954 million and liquidity ≈ $499 million); management expects annual interest expense of roughly $76 million, Q1 free cash flow was a use of $7 million (improving >$22 million YoY) against record 2025 free cash flow of $94 million with seasonally strongest cash generation expected in Q2–Q3, and the company plans modest incremental 2026 investments (~$10 million working capital and ~$5 million additional CapEx); Q1 metrics to frame this guidance: net sales $480 million, adjusted EBITDA $47.5 million (margin 9.9%, +220 bps), FAM sales $188 million with adj. EBITDA $27 million (margin 14.6%, +430 bps), SAS sales $291 million with adj. EBITDA ~ $31 million (margin 10.5%, +160 bps), and segment margins were restated ~100 bps lower after centralized cost allocations (consolidated adj. EBITDA unchanged).Mativ Holdings Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
38
Negative
Cash Flow
62
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.99B | 1.99B | 1.98B | 2.03B | 1.64B | 930.70M |
| Gross Profit | 352.90M | 299.70M | 364.10M | 355.80M | 306.00M | 183.20M |
| EBITDA | 159.10M | -249.50M | 139.60M | -270.90M | 70.70M | 81.00M |
| Net Income | 89.50M | -337.40M | -48.70M | -309.50M | -6.60M | 88.90M |
Balance Sheet | ||||||
| Total Assets | 1.99B | 2.05B | 2.45B | 2.64B | 3.67B | 2.42B |
| Cash, Cash Equivalents and Short-Term Investments | 66.30M | 84.20M | 94.30M | 120.20M | 101.10M | 74.70M |
| Total Debt | 1.03B | 1.12B | 1.15B | 1.17B | 1.74B | 1.30B |
| Total Liabilities | 1.52B | 1.55B | 1.59B | 1.69B | 2.49B | 1.74B |
| Stockholders Equity | 470.70M | 498.70M | 858.50M | 949.10M | 1.18B | 682.20M |
Cash Flow | ||||||
| Free Cash Flow | 127.70M | 93.80M | 39.20M | 40.20M | 142.60M | 19.20M |
| Operating Cash Flow | 161.00M | 133.80M | 94.80M | 106.60M | 202.20M | 58.10M |
| Investing Cash Flow | -35.20M | -37.00M | -56.70M | 547.20M | -481.30M | -636.50M |
| Financing Cash Flow | -160.00M | -106.70M | -55.90M | -662.90M | 331.60M | 599.90M |
Mativ Holdings Technical Analysis
Positive
11.68
Price Trends
9.88
Positive
9.20
Positive
10.18
Positive
Market Momentum
0.68
Positive
70.62
Negative
79.27
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MATV, the sentiment is Positive. The current price of 11.68 is below the 20-day moving average (MA) of 12.24, above the 50-day MA of 9.88, and above the 200-day MA of 10.18, indicating a bullish trend. The MACD of 0.68 indicates Positive momentum. The RSI at 70.62 is Negative, neither overbought nor oversold. The STOCH value of 79.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MATV.
Mativ Holdings Risk Analysis
Mativ Holdings disclosed 32 risk factors in its most recent earnings report. Mativ Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Mativ Holdings Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $4.65B | 19.13 | 7.92% | 1.72% | -4.72% | -24.05% | |
65 Neutral | $11.54B | 7.12 | 17.50% | 2.31% | 0.87% | 12.10% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | $698.71M | 7.72 | 19.47% | 3.18% | 1.06% | ― | |
56 Neutral | $4.77B | 84.91 | 3.11% | 1.76% | -14.37% | -81.88% | |
55 Neutral | $337.39M | -6.69 | -6.13% | ― | -1.93% | 48.75% | |
39 Underperform | $25.29M | -0.05 | -638.67% | 8.62% | -4.81% | -372.95% |
* Basic Materials Sector Average
MATV
Mativ Holdings
12.56
0.77
6.52%
CLW
Clearwater Paper
20.33
-0.99
-4.64%
LPX
Louisiana-Pacific
67.08
-27.16
-28.82%
MERC
Mercer International
0.38
-2.82
-88.06%
UFPI
UFP Industries
83.22
-15.61
-15.79%
SUZ
Suzano Papel e Celulose SA
9.23
-0.13
-1.44%
Mativ Holdings Corporate Events
Business Operations and StrategyExecutive/Board Changes
Mativ Holdings Appoints Independent Financial Expert to Board
Positive
Jul 1, 2026
On July 1, 2026, Mativ Holdings, Inc. expanded its board of directors from six to seven members and appointed Bruce Hausmann as a Class I director, with his term set to run until the 2029 annual meeting. Hausmann, currently vice president and chie...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.